PEPTIDEREPORT

Peer reviewed

Safety and feasibility of cerebrolysin in treatment of primary intracerebral hemorrhage (CLINCH)-a prospective, randomized, open-label, blinded endpoint pilot trial

Safety and feasibility of cerebrolysin in treatment of primary intracerebral hemorrhage (CLINCH)-a prospective, randomized, open-label, blinded endpoint pilot trial

PubMed / NCBIAccessed Aug 2, 2026

Open original source

Registry record

Source metadata

Publisher
PubMed / NCBI
Source type
Peer reviewed
Registry ID
pubmed-cerebrolysin-clinch-2025
PMID
41180520

Source usage

Linked from 3 pages

Compound

Cerebrolysin

Evidence curation

Best Peptides for Cognitive Enhancement

Guide

Peptide Half-Life Reference Table

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.